Transcarent CEO Glen Tullman previously led Livongo, which was purchased by Teladoc in a 2020 agreement that valued the ...

Transcarent has completed its merger with health benefits platform Accolade, the company announced Tuesday. The $621 million ...

Despite the still positive FCF generation and richer balance sheet, it remains to be seen when Teladoc's growth may ...

Livongo has also struck up relationships with other sectors of the industry, such as medical device and pharma companies, because, as Burke puts it, they see them as part of the same ecosystem ...

Under the terms of the deal, Teladoc is paying $11.33 in cash and a portion of its stock for each Livongo share, equivalent to around $159 per share. Livongo’s current share price is at around $129.

Abbott’s CGM device, the FreeStyle Libre, has been integrated with Glooko’s digital platform for diabetes management.

Note that in 2020, Teladoc dished out $18.5 billion to buy chronic care specialist Livongo Health. This new acquisition expands Teladoc's reach in at-home preventive care and chronic health ...

Download our guide to the digital therapeutics landscape, key providers, and market trends. Discover how digital health solutions can enhance pharmaceutical outcomes.